Bacterial Ortholog of Mammalian Translocator Protein (TSPO) with Virulence Regulating Activity

被引:19
|
作者
Chapalain, Annelise
Chevalier, Sylvie
Orange, Nicole
Murillo, Laurence
Papadopoulos, Vassilios
Feuilloley, Marc G. J.
机构
[1] Laboratory of Cold Microbiology, UPRES EA4312, University of Rouen, Evreux
[2] ADIPpharm, Evreux
[3] The Research Institute of the McGill University Health Centre, Department of Medicine, McGill University, Montreal, QC
来源
PLOS ONE | 2009年 / 4卷 / 06期
关键词
PERIPHERAL BENZODIAZEPINE-RECEPTOR; OUTER-MEMBRANE PROTEINS; PSEUDOMONAS-FLUORESCENS; IN-VIVO; BINDING; GROWTH; OPRF; STEROIDOGENESIS; SECONDARY; APOPTOSIS;
D O I
10.1371/journal.pone.0006096
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The translocator protein (TSPO), previously designated as peripheral-type benzodiazepine receptor, is a protein mainly located in the outer mitochondrial membrane of eukaryotic cells. TSPO is implicated in major physiological functions and functionally associated with other proteins such as the voltage-dependent anionic channel, also designated as mitochondrial porin. Surprisingly, a TSPO-related protein was identified in the photosynthetic bacterium Rhodobacter sphaeroides but it was initially considered as a relict of evolution. In the present study we cloned a tspO gene in Pseudomonas fluorescens MF37, a non-photosynthetic eubacterium and we used bioinformatics tools to identify TSPO in the genome of 97 other bacteria. P. fluorescens TSPO was recognized by antibodies against mouse protein and by PK 11195, an artificial ligand of mitochondrial TSPO. As in eukaryotes, bacterial TSPO appears functionally organized as a dimer and the apparent Kd for PK 11195 is in the same range than for its eukaryotic counterpart. When P. fluorescens MF37 was treated with PK 11195 (10(-5) M) adhesion to living or artificial surfaces and biofilm formation activity were increased. Conversely, the apoptotic potential of bacteria on eukaryotic cells was significantly reduced. This effect of PK11195 was abolished in a mutant of P. fluorescens MF37 deficient for its major outer membrane porin, OprF. The present results demonstrate the existence of a bacterial TSPO that shares common structural and functional characteristics with its mammalian counterpart. This protein, apparently involved in adhesion and virulence, reveals the existence of a possible new inter kingdom signalling system and suggests that the human microbiome should be involuntarily exposed to the evolutionary pressure of benzodiazepines and related molecules. This discovery also represents a promising opportunity for the development of alternative antibacterial strategies.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Translocator protein (TSPO): the new story of the old protein in neuroinflammation
    Lee, Younghwan
    Park, Youngjin
    Nam, Hyeri
    Lee, Ji-Won
    Yu, Seong-Woon
    BMB REPORTS, 2020, 53 (01) : 20 - 27
  • [22] Structural Prediction of the Dimeric Form of the Mammalian Translocator Membrane Protein TSPO: A Key Target for Brain Diagnostics
    Zeng, Juan
    Guareschi, Riccardo
    Damre, Mangesh
    Cao, Ruyin
    Kless, Achim
    Neumaier, Bernd
    Bauer, Andreas
    Giorgetti, Alejandro
    Carloni, Paolo
    Rossetti, Giulia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (09)
  • [23] The translocator protein (TSPO) is prodromal to mitophagy loss in neurotoxicity
    Frison, Michele
    Faccenda, Danilo
    Abeti, Rosella
    Rigon, Manuel
    Strobbe, Daniela
    England-Rendon, Britannie S.
    Cash, Diana
    Barnes, Katy
    Sadeghian, Mona
    Sajic, Marija
    Wells, Lisa A.
    Xia, Dong
    Giunti, Paola
    Smith, Kenneth
    Mortiboys, Heather
    Turkheimer, Federico E.
    Campanella, Michelangelo
    MOLECULAR PSYCHIATRY, 2021, 26 (07) : 2721 - 2739
  • [24] Translocator protein (TSPO) as an imaging target in pancreatic cancer
    McKinley, E. T.
    Tang, D.
    Merchant, N.
    Shi, C.
    Moses, H. L.
    Manning, H. C.
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 : 17 - 17
  • [25] The translocator protein (TSPO) is prodromal to mitophagy loss in neurotoxicity
    Michele Frison
    Danilo Faccenda
    Rosella Abeti
    Manuel Rigon
    Daniela Strobbe
    Britannie S. England-Rendon
    Diana Cash
    Katy Barnes
    Mona Sadeghian
    Marija Sajic
    Lisa A. Wells
    Dong Xia
    Paola Giunti
    Kenneth Smith
    Heather Mortiboys
    Federico E. Turkheimer
    Michelangelo Campanella
    Molecular Psychiatry, 2021, 26 : 2721 - 2739
  • [26] Evolving understanding of translocator protein 18 kDa (TSPO)
    Li, Fei
    Liu, Jian
    Garavito, R. Michael
    Ferguson-Miller, Shelagh
    PHARMACOLOGICAL RESEARCH, 2015, 99 : 404 - 409
  • [27] An update into the medicinal chemistry of translocator protein (TSPO) ligands
    Barresi, Elisabetta
    Robello, Marco
    Costa, Barbara
    Da Pozzo, Eleonora
    Baglini, Emma
    Salerno, Silvia
    Da Settimo, Federico
    Martini, Claudia
    Taliani, Sabrina
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 209
  • [28] Mitochondrial translocator protein (TSPO): From physiology to cardioprotection
    Morin, Didier
    Musman, Julien
    Pons, Sandrine
    Berdeaux, Alain
    Ghaleh, Bijan
    BIOCHEMICAL PHARMACOLOGY, 2016, 105 : 1 - 13
  • [29] The translocator protein (TSPO): A novel target for cancer chemotherapy
    Austin, Christopher J. D.
    Kahlert, Jan
    Kassiou, Michael
    Rendina, Louis M.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2013, 45 (07): : 1212 - 1216
  • [30] Translocator Protein (TSPO) and Neurosteroids: Implications in Psychiatric Disorders
    Da Pozzo, E.
    Costa, B.
    Martini, C.
    CURRENT MOLECULAR MEDICINE, 2012, 12 (04) : 426 - 442